Literature DB >> 22422902

Monitoring for tuberculosis drug hepatotoxicity: moving from opinion to evidence.

Jussi J Saukkonen, Krista Powell, John A Jereb.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22422902     DOI： 10.1164/rccm.201112-2174ED

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  6 in total

1.  Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline.

Authors:  Payam Nahid; Sundari R Mase; Giovanni Battista Migliori; Giovanni Sotgiu; Graham H Bothamley; Jan L Brozek; Adithya Cattamanchi; J Peter Cegielski; Lisa Chen; Charles L Daley; Tracy L Dalton; Raquel Duarte; Federica Fregonese; C Robert Horsburgh; Faiz Ahmad Khan; Fayez Kheir; Zhiyi Lan; Alfred Lardizabal; Michael Lauzardo; Joan M Mangan; Suzanne M Marks; Lindsay McKenna; Dick Menzies; Carole D Mitnick; Diana M Nilsen; Farah Parvez; Charles A Peloquin; Ann Raftery; H Simon Schaaf; Neha S Shah; Jeffrey R Starke; John W Wilson; Jonathan M Wortham; Terence Chorba; Barbara Seaworth
Journal:  Am J Respir Crit Care Med       Date:  2019-11-15       Impact factor: 21.405

2.  Accelerating Early Antituberculosis Drug Discovery by Creating Mycobacterial Indicator Strains That Predict Mode of Action.

Authors:  Maikel Boot; Susanna Commandeur; Amit K Subudhi; Meriem Bahira; Trever C Smith; Abdallah M Abdallah; Mae van Gemert; Joël Lelièvre; Lluís Ballell; Bree B Aldridge; Arnab Pain; Alexander Speer; Wilbert Bitter
Journal:  Antimicrob Agents Chemother       Date:  2018-06-26       Impact factor: 5.191

3.  Real-time imaging of oxidative and nitrosative stress in the liver of live animals for drug-toxicity testing.

Authors:  Adam J Shuhendler; Kanyi Pu; Lina Cui; Jack P Uetrecht; Jianghong Rao
Journal:  Nat Biotechnol       Date:  2014-03-23       Impact factor: 54.908

4.  Effect of Prophylactic Use of Silymarin on Anti-tuberculosis Drugs Induced Hepatotoxicity.

Authors:  Eunyoung Heo; Deog Kyeom Kim; So Hee Oh; Jung-Kyu Lee; Ju-Hee Park; Hee Soon Chung
Journal:  Tuberc Respir Dis (Seoul)       Date:  2017-07-03

5.  Liver toxicity associated with tuberculosis chemotherapy in the REMoxTB study.

Authors:  Conor Duncan Tweed; Genevieve Helen Wills; Angela M Crook; Rodney Dawson; Andreas H Diacon; Cheryl E Louw; Timothy D McHugh; Carl Mendel; Sarah Meredith; Lerato Mohapi; Michael E Murphy; Stephen Murray; Sara Murthy; Andrew J Nunn; Patrick P J Phillips; Kasha Singh; M Spigelman; S H Gillespie
Journal:  BMC Med       Date:  2018-03-28       Impact factor: 8.775

6.  A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TB.

Authors:  C D Tweed; G H Wills; A M Crook; E Amukoye; V Balanag; A Y L Ban; A L C Bateson; M C Betteridge; W Brumskine; J Caoili; R E Chaisson; M Cevik; F Conradie; R Dawson; A Del Parigi; A Diacon; D E Everitt; S M Fabiane; R Hunt; A I Ismail; U Lalloo; L Lombard; C Louw; M Malahleha; T D McHugh; C M Mendel; F Mhimbira; R N Moodliar; V Nduba; A J Nunn; I Sabi; M A Sebe; R A P Selepe; S Staples; S Swindells; C H van Niekerk; E Variava; M Spigelman; S H Gillespie
Journal:  Int J Tuberc Lung Dis       Date:  2021-04-01       Impact factor: 2.373
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.